Northern Trust
ICVX

Northern Trust’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Northern Trust’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-282,513
Closed -$4.45M – 4528
2023
Q4 		$4.45M Buy
282,513
+10,904
+4% +$105K ﹤0.01% 2571
2023
Q3 		$2.1M Buy
271,609
+28,686
+12% +$238K ﹤0.01% 2911
2023
Q2 		$2.41M Buy
242,923
+70,657
+41% +$566K ﹤0.01% 2905
2023
Q1 		$999K Sell
172,266
-8,268
-5% -$71.4K ﹤0.01% 3220
2022
Q4 		$1.43M Buy
180,534
+14,115
+8% +$60.6K ﹤0.01% 3146
2022
Q3 		$526K Sell
166,419
-1,813
-1% -$11.3K ﹤0.01% 3492
2022
Q2 		$964K Sell
168,232
-20,520
-11% -$160K ﹤0.01% 3352
2022
Q1 		$1.33M Buy
188,752
+67,963
+56% +$1.07M ﹤0.01% 3293
2021
Q4 		$2.76M Buy
120,789
+2,605
+2% +$67.3K ﹤0.01% 3055
2021
Q3 		$3.5M Buy
+118,184
New +$4.01M ﹤0.01% 2964

Northern Trust's ICVX Position: Q1 2024 in Review

Northern Trust sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 282,513 shares — an estimated $4.45M sold.

Northern Trust first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $4.45M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Northern Trust reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 282,513 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $4.45M.
  • Northern Trust first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Northern Trust's Icosavax, Inc. Common Stock position peaked at $4.45M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.